Product image of Moflok (Moxifloxacin Hydrochloride) supplied by GNH India

Moflok

Active Ingredient:
Moxifloxacin Hydrochloride
Origin:
EU

Moflok (Moxifloxacin Hydrochloride)

Moxifloxacin Hydrochloride, the active ingredient in Moflok, is a fluoroquinolone presented as an ophthalmic eye drop for ophthalmic use. It treats bacterial conjunctivitis, keratitis and other ocular bacterial infections in patients who require prescription antimicrobial therapy.

GNH India supplies Moflok as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with distribution aligned to EU regulatory standards and a commitment to quality across multiple continents. The product complies with EU pharmacopeia specifications and is intended for professional use.

Manufacturer / TM Owner

Laboratório Edol - Produtos Farmacêuticos, S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Moflok (moxifloxacin hydrochloride) is a fluoroquinolone antibacterial indicated for bacterial infections of the eye.

  • Bacterial conjunctivitis: reduces bacterial load and resolves inflammation in the infected conjunctiva.
  • Keratitis: eradicates causative bacteria and promotes corneal healing.
  • Blepharitis: controls bacterial overgrowth on eyelid margins.
  • Post‑surgical ocular infection: prevents or treats bacterial contamination after eye surgery.
  • Other ocular bacterial infections: treats bacterial involvement in conditions such as postoperative eye infections or marginal keratitis.

How It Works

  • Moxifloxacin hydrochloride inhibits bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, enzymes essential for DNA supercoiling and replication. By binding to the quinolone‑binding site, it prevents relaxation of supercoiled DNA, halting bacterial DNA synthesis and transcription, which leads to bacterial cell death. This broad‑spectrum activity covers Gram‑positive and Gram‑negative ocular pathogens.

Side Effects

Moflok may cause ocular adverse reactions, which are categorized by frequency.

Common Side Effects

  • Eye irritation or burning sensation.
  • Transient redness of the conjunctiva.
  • Increased tearing.
  • Temporary blurred vision.

Serious or Rare Side Effects

  • Corneal ulceration or stromal thinning.
  • Severe allergic reaction, including angioedema.
  • Sudden loss of vision.

Precautions & Warnings

When prescribing Moflok, consider the following precautions:

  • Assess patient for known hypersensitivity to fluoroquinolones: avoid use if allergic.
  • Use only for indicated bacterial infections: do not treat viral conjunctivitis.
  • Monitor for signs of corneal toxicity: discontinue if severe irritation persists.
  • Avoid concomitant use with contact lenses unless advised: lenses may retain drug.
  • Pregnancy and lactation: safety not established; weigh benefits and risks.
  • Store at room temperature: keep in original container, protect from light and moisture.

Avoid Interactions

Moflok can interact with other ophthalmic agents; review the following interactions.

Major Interactions (Avoid)

  • Concurrent use with other ophthalmic fluoroquinolones: increased risk of ocular toxicity.
  • Systemic fluoroquinolones: may potentiate systemic side effects such as tendon disorders.
  • Topical corticosteroids: may mask signs of infection and delay healing.

Moderate Interactions (Monitor Closely)

  • Anticholinergic eye drops: may affect pupil response.
  • Herbal ocular preparations: possible reduced efficacy of the antibiotic.
  • Contact lens solutions containing preservatives: may cause additional irritation.

Frequently Asked Questions

Moflok is an ophthalmic eye drop containing moxifloxacin hydrochloride. It is prescribed to treat bacterial infections of the eye such as bacterial conjunctivitis, keratitis and other ocular bacterial conditions, helping to eliminate the causative microorganisms and reduce inflammation.

Moxifloxacin inhibits bacterial DNA gyrase and topoisomerase IV, enzymes required for DNA replication and transcription. By blocking these enzymes, the drug prevents bacterial DNA synthesis, leading to bacterial cell death and resolution of the infection in ocular tissues.

The dosing regimen for Moflok is determined by the prescribing clinician based on the specific infection, severity, and patient factors. The prescriber will provide detailed instructions on the number of drops, frequency, and duration of therapy.

Safety data for moxifloxacin ophthalmic use in pregnancy and lactation are limited. The prescriber should evaluate the potential benefits against any possible risks before initiating therapy in pregnant or nursing patients.

To order Moflok, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Moflok belongs to the fluoroquinolone class, offering broad‑spectrum activity against many Gram‑positive and Gram‑negative ocular pathogens. Compared with older agents such as ciprofloxacin, moxifloxacin often provides enhanced potency and a lower dosing frequency, but the choice depends on local resistance patterns and clinician preference.

Moflok should be stored at room temperature, below 25 °C, in its original packaging. Keep the bottle tightly closed, protect it from light and moisture, and discard any solution that appears discolored or contaminated.

Moflok is applied as eye drops. The patient should wash their hands, tilt the head back, pull down the lower eyelid, and place the prescribed number of drops into the conjunctival sac. The eye should be closed gently for a few seconds to allow absorption.

Serious adverse events, although rare, include corneal ulceration, severe allergic reactions such as angioedema, and sudden loss of vision. Patients should seek immediate medical attention if they experience intense pain, worsening redness, visual changes, or signs of an allergic response.

Moflok should not be used by individuals with a known hypersensitivity to moxifloxacin, other fluoroquinolones, or any component of the formulation. It is also contraindicated for viral or non‑bacterial eye conditions where an antibacterial agent would be ineffective.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.